The utility of procalcitonin for diagnosing bacteremia and bacterial pneumonia in hospitalized oncology patients

被引:0
作者
Mary K. Munsell
Temidayo Fadelu
Sherri O. Stuver
Katherine P. Baker
Brett Glotzbecker
Justin L. Simmons
Kerry L. Reynolds
Ami K. Patel
机构
[1] Harvard Medical School,School of Public Health
[2] Dana-Farber Cancer Institute,undefined
[3] Brigham and Women’s Hospital,undefined
[4] Boston University,undefined
[5] Massachusetts General Hospital,undefined
来源
Journal of Cancer Research and Clinical Oncology | 2023年 / 149卷
关键词
Procalcitonin; Oncology; Inpatient; Bacteremia; Pneumonia; Diagnostic marker;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:5193 / 5204
页数:11
相关论文
共 191 条
  • [1] Abbasi A(2010)Plasma procalcitonin is associated with obesity, insulin resistance, and the metabolic syndrome J Clin Endocr Metab 95 E26-31
  • [2] Corpeleijn E(2015)Lung cancer may increase serum procalcitonin level Infect Disord Drug Targets 15 57-63
  • [3] Postmus D(2018)Higher cut-off serum procalcitonin level for sepsis diagnosis in metastatic solid tumor patients BMC Res Notes 11 84-344
  • [4] Gansevoort RT(2020)Clinical utility of procalcitonin in bacterial infections in patients undergoing hematopoietic stem cell transplantation Am J Blood Res 10 339-615
  • [5] De Jong PE(2015)STARD 2015: An updated list of essential items for reporting diagnostic accuracy studies Brit Med J 351 611-340
  • [6] Gans ROB(2010)Procalcitonin as a predictive marker of infections in chemoinduced neutropenia J Cancer Res Clin Oncol 136 337-475
  • [7] Struck J(2003)Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes? Ann Rheum Dis 62 A4984-1165
  • [8] Avrillon V(2014)Procalcitonin and C-reactive protein as markers of bacterial infection in patients with solid tumours Dan Med J 61 469-503
  • [9] Locatelli-Sanchez M(2016)Utility of blood procalcitonin concentration in the management of cancer patients with infections Onco Targets Ther 9 1163-359
  • [10] Folliet L(2010)Circulating procalcitonin in aseptic carcinoma patients: A specificity study with (18)F-fluorodeoxyglucose positron-emission tomography/computed tomography as benchmark Clin Chem Lab Med 48 485-481